Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease

New England Journal of Medicine

Volumn 360, Issue 10, 2009, Pages 961-972

  Serruvs, Patrick W ^a   Morice, Marie Claude ^b   Kappetein, A Pieter ^a   Colombo, Antonio ^c   Holmes, David R ^d   Mack, Michael J ^e   Ståhle, Elisabeth ^f   Feldman, Ted E ^g   Van Den Brand, Marcel ^a   Bass, Eric J ^h   Van Dyck, Nic ^h   Leadley, Katrin ^h   Dawkins, Keith D ^h   Mohr, Friedrich W ⁱ  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d MAYO CLINIC   (United States)

^e Medical City Hospital   (United States)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^g EVANSTON HOSPITAL   (United States)

^h BOSTON SCIENTIFIC CORPORATION   (United States)

ⁱ UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; THIENOPYRIDINE DERIVATIVE; UNCLASSIFIED DRUG; WARFARIN DERIVATIVE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT OUTCOME; CARDIOVASCULAR DISEASE; CLASSIFICATION; COMPARATIVE STUDY; HOSPITALIZATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; RETREATMENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETREATMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 61849104535     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0804626     Document Type: Article

References (39)

1. Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. Ann Thorac Surg 1968;5:334-9.
2. Buxton BP, Komeda M, Puller JA, Gordon I. Bilateral internal thoracic artery grafting may improve outcome of coronary artery surgery: risk-adjusted survival. Circulation 1998;98:Suppl:II-l-II-6.
3. Flynn M, Reddy S, Shepherd W, et al. Fast-tracking revisited: routine cardiac surgical patients need minimal intensive care. Eur J Cardiothorac Surg 2004;25:116-22.
4. Janssen DP, Noyez L, Wouters C, Brouwer RM. Preoperative prediction of prolonged stay in the intensive care unit for coronary bypass surgery. Eur J Cardiothorac Surg 2004;25:203-7.
5. Tavilla G, Kappetein AP, Braun J, Gopie J, Tjien AT, Dion RA. Long-term follow-up of coronary artery bypass grafting in three-vessel disease using exclusively pedicled bilateral internal thoracic and right gastroepiploic arteries. Ann Thorac Surg 2004;77:794-9.
6. Barner HB. Operative treatment of coronary atherosclerosis. Ann Thorac Surg 2008;85:1473-82.
7. Grüntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet 1978;1: 263.
8. Bittl JA. Advances in coronary angioplasty. N Engl J Med 1996;335:1290-302. [Erratum, N Engl J Med 1997;336:670.]
9. Serruys PW, Kutryk MJB, Ong ATL. Coronary-artery stents. N Engl J Med 2006; 354:483-95.
10. Booth J, Clayton T, Pepper J, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation 2008;118:381-8.
11. Daemen J, Boersma E, Flather M, et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a metaanalysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008;118:1146-54.
12. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008;358:331-41.
13. Brener SJ, Galla JM, Bryant R III, Sabik JF III, Ellis SG. Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients. Am J Cardiol 2008;101:169-72.
14. Briguori C, Condorelli G, Airoldi P, et al. Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Am J Cardiol 2007;99:779-84.
15. Buszman PE, Kiesz SR, Bochenek A, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol 2008;51:538-45.
16. Chieffo A, Morici N, Maisano P, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 2006;113: 2542-7.
17. Herz I, Moshkovitz Y, Loberman D, et al. Drug-eluting stents versus bilateral internal thoracic grafting for multivessel coronary disease. Ann Thorac Surg 2005; 80:2086-90.
18. Javaid A, Steinberg DH, Buch AN, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 2007;116:Suppl:I-200-I-206.
19. Lee MS, Jamal P, Kedia G, et al. Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease. Int J Cardiol 2007;123: 34-42.
20. Lee MS, Kapoor N, Jamal P, et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2006;47:864-70.
21. Palmerini T, Barlocco P, Santarelli A, et al. A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years). Eur Heart J 2007;28:2714-9.
22. Sanmartin M, Baz JA, Claro R, et al. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. Am J Cardiol 2007; 100:970-3.
23. Yang ZK, Shen WP, Zhang RY, et al. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease. J Interv Cardiol 2007;20:10-6.
24. Serruys PW, Daemen J, Morice M-C, et al. Three-year follow-up of the ARTS-II- sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. EuroIntervention 2007;3: 450-9.
25. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007;370:937-48.
26. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/ AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006; 47(l):el-el21.
27. Kappetein AP, Dawkins KD, Mohr FW, et al. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease: insights from the SYNTAX run-in phase. Eur J Car-diothorac Surg 2006;29:486-91.
28. Ong AT, Serruys PW, Mohr FW, et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 2006;151: 1194-204.
29. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. Eurolntervention 2005;1:219-27.
30. King SB III, Smith SC Jr, Hirshfeld JW Jr, et al. 2007 Focused update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 2008;117:261-95. [Erratum, Circulation 2008;117(6):el61J
31. Nashef SA, Roques F, Michel P, Gaud-ucheau E, Lemeshow S, Salamon R. European System for Cardiac Operative Risk Evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9-13.
32. Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 1989;79:I-3-I-12. [Erratum, Circulation 1990;82:1078J
33. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
34. Bravata DM, Gienger AL, McDonald KM, etal. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 2007; 147:703-16.
35. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369:667-78.
36. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356: 1020-9.
37. Leaman DM, Brower RW, Meester GT, Serruys P, van den Brand M. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation 1981;63:285-99.
38. Valgimigli M, Serruys PW, Tsuchida K, et al. Cyphering the complexity of coronary artery disease using the Syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 2007;99:1072-81.
39. van den Brand MJBM, Rensing BJWM, Morel MM, et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol 2002;39:559-64.